# SIROLIMUS
> **ANDA211212** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2019-10-18
## Drug
- **FDA Application Number:** ANDA211212
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SIROLIMUS
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2019-10-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211212)
---
*MORVS · CC0 1.0*